Evidence map›Paper›PMID 26857144›Full record

ArticleScientific reports2016

Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cells.

Yong-Sun Maeng, Rina Lee, Boram Lee, Seung-Il Choi, Eung Kweon Kim

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05221593 (Evaluation of Lithium Efficacy Against Chemotherapy Induced Neutropenia in Breast Cancer Patients), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05221593 phase3completednot on this mapstarted 2020, after this paper: background citation

Evaluation of Lithium Efficacy Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

TypeinterventionalSponsorAl-Azhar UniversityRan2020 to 2022Enrolled50ConditionsNeutropeniaArmsLithium Carbonate
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Lithium: A Promising Anticancer Agent.Life (Basel, Switzerland) · 2023
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Improved detection of synthetic lethal interactions inProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yong-Sun MaengDepartment of Ophthalmology, Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Rina LeeDepartment of Ophthalmology, Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Boram LeeDepartment of Ophthalmology, Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Seung-Il ChoiDepartment of Ophthalmology, Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Eung Kweon KimDepartment of Ophthalmology, Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Yonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis is the main cause of mortality in cancer patients. Although there are many anti-cancer drugs targeting tumor growth, anti-metastatic agents are rarely developed. Angiogenesis and lymphangiogenesis are crucial for cancer progression; in particular, lymphangiogenesis is pivotal for metastasis in cancer. Here we report that lithium inhibits colon cancer metastasis by blocking lymphangiogenesis. Lithium reduces the expression of transforming growth factor-β-induced protein (TGFBIp) in colon cancer cells by inhibiting Smad3 phosphorylation via GSK3β inactivation. Moreover, lithium inhibits lymphatic endothelial cell migration, which is increased upon TGFBIp expression in tumor cells. Lithium had no significant effect on SW620 tumor growth in vitro and in vivo; however, it inhibited lymphangiogenesis in tumors. In tumor xenografts model, lithium was found to prevent metastasis to the lungs, liver, and lymph nodes by inhibiting TGFBIp-induced tumor lymphangiogenesis. Collectively, our findings demonstrate a novel role of lithium in the inhibition of colon cancer metastasis by blocking TGFBIp expression, and thereby TGFBIp-induced lymphangiogenesis, in primary tumors.

Indexed as

AnimalsbetaIG-H3 ProteinCell Line, TumorColonic NeoplasmsExtracellular Matrix ProteinsGene Expression Regulation, NeoplasticGlycogen Synthase Kinase 3 betaLithiumLymphangiogenesisMiceNeoplasm MetastasisNeoplasm ProteinsPhosphorylationSmad3 ProteinTransforming Growth Factor betabetaIG-H3 ProteinExtracellular Matrix ProteinsGlycogen Synthase Kinase 3 betaGsk3b protein, mouseLithiumNeoplasm ProteinsSmad3 ProteinSmad3 protein, mouseTransforming Growth Factor beta

Identifiers

PMID26857144
PMCPMC4746585
OpenAlexW2254918958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.